(lp0
S'Meridian Bioscience, Inc. Expects to Report Second Quarter Fiscal 2017 ... GlobeNewswire  - Mar 29, 2017 CINCINNATI, March 29, 2017  -- Meridian Bioscience, Inc. , a leading diagnostic and life science component company, expects to release its second quarter fiscal 2017 operating results before the NASDAQ market opens&nbsp;...Meridian Bioscience, Inc.  Now Covered by Analysts at CL King - Community Financial News'
p1
aS'Meridian Bioscience, Inc. Receives FDA Clearance for New Molecular Test for ... GlobeNewswire  - Jun 15, 2016 CINCINNATI, June 15, 2016  -- Meridian Bioscience, Inc.  today announced that it has received FDA clearance for a new molecular diagnostic test for Mycoplasma pneumonia (M.'
p2
aS"Here's Why Meridian Bioscience, Inc. Stock Is Having a Rough Day Motley Fool - Jan 25, 2017 Shares of Meridian Bioscience, Inc. , a diagnostics-focused life-science company, fell hard at the open Wednesday, and were still off about 19.8% at 12:01 p.m.Meridian Bioscience stock drops 9% on first-quarter earnings and revenue ... - MarketWatchMeridian Bioscience Q1 Results Miss View; Cuts Dividend And FY17 Outlook - Nasdaq"
p3
aS'Meridian Bioscience, Inc.  loses confidence of 19 hedge fund managers Post Analyst - 18 hours ago Meridian Bioscience, Inc.  reached 25.88% versus a 1-year low price of $10.75. The stock was last seen -1.47% lower, reaching at $13.4 on Apr. 13, 2017.Meridian Bioscience, Inc.  Receives New Coverage from Analysts at CL King - The Cerbat GemMeridian Bioscience, Inc.  Reaches $13.68 After 9.00% Up Move, Ashford ... - MoneyMakingArticles'
p4
aS'Meridian Bioscience Inc.  Moves Lower on Volume Spike for April 07 Equities.com - Apr 7, 2017 Meridian Bioscience Inc.  traded on unusually high volume on Apr. 07, as the stock lost 0.37% to close at $13.50. On the day, Meridian Bioscience Inc. saw 856,307 shares trade hands on 3,169 trades. Considering that the stock averages only a ...Analysts Set Meridian Bioscience, Inc.  Target Price at $13.50 - The Cerbat GemMeridian Bioscience, Inc.  Shares Bought by Thrivent Financial for Lutherans - BNB Daily '
p5
aS'Magellan Diagnostics  Signs Exclusive ... GlobeNewswire  - Dec 20, 2016 CINCINNATI, Dec. 20, 2016  -- Meridian Bioscience, Inc.  today announced that its Magellan Diagnostics business unit has signed an exclusive distribution agreement with MedCaptain Medical Technology Co.'
p6
aS'Market View: Looking at the Technicals for Meridian Bioscience, Inc.  Searcy News - 17 hours ago Tracking shares of Meridian Bioscience, Inc. , the company has a current EV  of 573856.'
p7
aS'Stock Focus: Checking the Chart for Meridian Bioscience, Inc.  The Standard - 19 hours ago Checking the Value Composite score for Meridian Bioscience, Inc. , we see that the company has a rank of 43.'
p8
aS'Meridian Bioscience Reports Fourth Quarter and Full-Year Operating Results ... GlobeNewswire  - Nov 10, 2016 reported fourth quarter fiscal 2016 net earnings of $5.5 million, or $0.13 per diluted share, on a GAAP basis, a 35% decrease compared to the fiscal 2015 fourth quarter.'
p9
aS"ECCMID Presentation to Demonstrate Revolutionary Breakthrough in Malaria Detection GlobeNewswire  - Apr 17, 2017 Dr. van Gool's research focused on the efficacy of illumigene Malaria, a molecular-based, field laboratory-deployed test for malaria developed by Meridian Bioscience, Inc. of Cincinnati, Ohio . The test, which is up to 80,000 times more&nbsp;..."
p10
a.